Multinodular focal fatty infiltration of the liver: Atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 3, 2006, Pages 690-694

  Marin, Daniele ^a   Iannaccone, Riccardo ^a   Catalano, Carlo ^a   Passariello, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Contrast agents; Liver; MR; Steatosis

Indexed keywords

CONTRAST MEDIUM; FAT; GADOBENATE DIMEGLUMINE; GADOBENIC ACID;

ADULT; ARTICLE; CASE REPORT; CELL INFILTRATION; DIAGNOSTIC IMAGING; DRUG UPTAKE; EVALUATION; EXTRACELLULAR FLUID; FATTY LIVER; HEPATOBILIARY PARAMETERS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGE QUALITY; LIVER BIOPSY; LIVER EXAMINATION; LIVER INJURY; LIVER METASTASIS; LIVER NODULE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE DIAGNOSIS; SIGNAL DETECTION; T1 WEIGHTED IMAGING;

ADULT; CONTRAST MEDIA; FATTY LIVER; HEPATITIS C; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748275912     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20660     Document Type: Article

References (21)

1. el-Hassan AY, Ibrahim EM, al-Mulhim FA, Nabhan AA, Chammas MY. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992;65:774-778.
2. Kroncke TJ, Taupitz M, Kivelitz D, et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 2000;10:1095-1100.
3. Kemper J, Jung G, Poll LW, Jonkmanns C, Luthen R, Moedder U. CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging 2002;27:708-710.
4. Yates CK, Streight RA. Focal fatty infiltration of the liver simulating metastatic disease. Radiology 1986;159:83-84.
5. Baker ME, Silverman PM. Nodular focal fatty infiltration of the liver: CT appearance. AJR Am J Roentgenol 1985;145:79-80.
6. Flournoy JG, Potter JL, Sullivan BM, Gerza CB, Ramzy I. CT appearance of multifocal hepatic steatosis. J Comput Assist Tomogr 1984;8:1192-1194.
7. Halvorsen RA, Korobkin M, Ram PC, Thompson WM. CT appearance of focal fatty infiltration of the liver. AJR Am J Roentgenol 1982;139:277-281.
8. Mitchell DG, Kim I, Chang TS, et al. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991;26:1041-1052.
9. Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005;25:321-331.
10. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 1999;6:282-291.
11. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980;137:727-729.
12. Baron RL, Oliver 3rd JH, Dodd 3rd GD, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996;199:505-511.
13. Lim JH, Choi D, Kim SH, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual phase helical CT. AJR Am J Roentgenol 2002;179:67-73.
14. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology 1997;203:575-577.
15. Petersein J, Spinazzi A, Giovagnoni A, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging-a multicenter phase III clinical study. Radiology 2000;215:727-736.
16. Kim YK, Jeong JM, Chong SK. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004;14:5-13.
17. Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001;221:731-739.
18. Davies BE, Kirchin MA, Bensel K, et al. Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function. Invest Radiol 2002;37:299-308.
19. de Haën C, Lorusso V, Tirone P. Hepatic transport of gadobenate dimeglumine in TR-rats. Acad Radiol 1993;2:232-238.
20. de Haën C, Lorusso V. Luzzani F, et al. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat. Acad Radiol 1995;2:232-238.
21. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236:166-177.